Recursion Pharmaceuticals (RXRX) Net Margin (2020 - 2026)
Recursion Pharmaceuticals' Net Margin came in at -1708.02% for Q2 2026, down 813.79 percentage points from -894.23% a year earlier but up 107.56 percentage points from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Net Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Recursion Pharmaceuticals reported Net Margin of -945.92%, up 58.99 percentage points year-over-year; for FY2025, it was -863.35%, down 75.33 percentage points from FY2024.
- Net Margin has declined in each of the last three years, though with a five-year change of +1332.66 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -788.02% in FY2024 (-52.03 pp), -735.99% in FY2023 (-134.94 pp), -601.05% in FY2022 (+1231.13 pp) and -1832.18% in FY2021 (+363.83 pp).
- The five-year range for quarterly Net Margin is -3935.46% (Q4 2024) to -304.24% (Q4 2025).
- Year-over-year, Net Margin increased in two of the last eight quarters, with an average year-over-year change of -485.90 percentage points.
- The fastest year-over-year change in Net Margin over five years came in Q4 2025 (a gain of 3631.22 percentage points), and the weakest in Q4 2024 (a drop of 3081.58 percentage points).
- Business Quant data shows RXRX's Net Margin at -1815.57% (Q1 2026), -304.24% (Q4 2025) and -3135.32% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | -1,708.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,708.02% |
| Mar 31, 2026 | -1,815.57% |
| Dec 31, 2025 | -304.24% |
| Sep 30, 2025 | -3,135.32% |
| Jun 30, 2025 | -894.23% |
| Mar 31, 2025 | -1,373.26% |
| Dec 31, 2024 | -3,935.46% |
| Sep 30, 2024 | -367.46% |
| Jun 30, 2024 | -676.56% |
| Mar 31, 2024 | -662.41% |
| Dec 31, 2023 | -853.88% |
| Sep 30, 2023 | -883.10% |
| Jun 30, 2023 | -696.43% |
| Mar 31, 2023 | -538.38% |
| Dec 31, 2022 | -420.39% |
| Sep 30, 2022 | -459.31% |
| Jun 30, 2022 | -854.31% |
| Mar 31, 2022 | -1,049.67% |
| Dec 31, 2021 | -2,563.48% |
| Sep 30, 2021 | -1,871.67% |
API Access
Recursion Pharmaceuticals Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();